Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

Presentation TCT 2014

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou

September 16, 2014

Presentation TCT 2014

Percutaneous Left Atrial Access Using the Novel CorQuest HeartXs Device

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, David L. Brown, Pedro Martinez-Clark

September 14, 2014

Presentation TCT 2014

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Matthew J. Price

September 13, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

Case #3: LAA Closure With a Novel Device

Presenter: Wolfgang Bocksch

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Presenter: Gerald Werner

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Presenter: Saibal Kar

October 28, 2013

Advertisement

What’s Going to Be Hot at TCT 2025

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Novel LAA Closure Device Shows Promise in Early Experience

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Percutaneous Left Atrial Access Using the Novel CorQuest HeartXs Device

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Case #3: LAA Closure With a Novel Device

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content